
BioArctic AB
STO:BIOA B

Intrinsic Value
The intrinsic value of one
BIOA B
stock under the Base Case scenario is
190.42
SEK.
Compared to the current market price of 175.5 SEK,
BioArctic AB
is
Undervalued by 8%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
BioArctic AB
Fundamental Analysis


Revenue & Expenses Breakdown
BioArctic AB
Balance Sheet Decomposition
BioArctic AB
Current Assets | 1B |
Cash & Short-Term Investments | 512.9m |
Other Current Assets | 497.7m |
Non-Current Assets | 101m |
Long-Term Investments | 3.4m |
PP&E | 96.6m |
Other Non-Current Assets | 957k |
Free Cash Flow Analysis
BioArctic AB
SEK | |
Free Cash Flow | SEK |
Earnings Waterfall
BioArctic AB
Revenue
|
257.4m
SEK
|
Cost of Revenue
|
-27m
SEK
|
Gross Profit
|
230.4m
SEK
|
Operating Expenses
|
-458.9m
SEK
|
Operating Income
|
-228.5m
SEK
|
Other Expenses
|
51.4m
SEK
|
Net Income
|
-177.1m
SEK
|
BIOA B Profitability Score
Profitability Due Diligence
BioArctic AB's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

Score
BioArctic AB's profitability score is 47/100. The higher the profitability score, the more profitable the company is.
BIOA B Solvency Score
Solvency Due Diligence
BioArctic AB's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

Score
BioArctic AB's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
BIOA B Price Targets Summary
BioArctic AB
Dividends
Current shareholder yield for BIOA B is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
BIOA B
stock under the Base Case scenario is
190.42
SEK.
Compared to the current market price of 175.5 SEK,
BioArctic AB
is
Undervalued by 8%.